Abbott Strikes Back In Thailand Drug Feud

Law360, New York (March 13, 2007, 12:00 AM EDT) -- Raising the stakes in a battle between Thai authorities and multinational pharmaceutical companies, Abbott Laboratories has decided against launching any new medicines in Thailand and has pulled its current drug applications from the government review process.

"The [Thai] government has decided not to support innovation by breaking patents of numerous medicines," Abbott spokesperson Jennifer Smoter said Tuesday. "That's why Abbott will not submit applications to register new medicines and has withdrawn current applications in Thailand, until the government changes its position."

Abbott has withdrawn its application...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.